Skip to main content
. Author manuscript; available in PMC: 2020 Dec 11.
Published in final edited form as: Int J Hyperthermia. 2020;37(1):66–75. doi: 10.1080/02656736.2019.1707886

Figure 1.

Figure 1.

Effects of MNP/AMF hyperthermia on the CEM43 thermal dose for varying conditions of MNPs concentration and AMF intensity. (A) A schematic diagram on the experimental procedure for the application of MNP/AMF hyperthermia to the biofilm bacteria in vitro. (B) Increase in temperature (ΔT) during the application of MNP/AMF as a function of MNP concentration (1–3 mg/mL) and AMF intensity (18, 24, and 30 kA/m). N = 3 per group. (C) Estimation of CEM43 values in response to MNP/AMF hyperthermia as a function of MNP concentration (1–3 mg/mL) and AMF intensity (18, 24, and 30 kA/m). The dotted red line indicates the reported threshold of the safe thermal dose for the application of hyperthermia to skin tissue [20]. N = 3 per group.